Unknown

Dataset Information

0

MetAP2 inhibition reduces food intake and body weight in a ciliopathy mouse model of obesity.


ABSTRACT: The ciliopathies Bardet-Biedl syndrome and Alström syndrome are genetically inherited pleiotropic disorders with hyperphagia and obesity as primary clinical features. Methionine aminopeptidase 2 inhibitors (MetAP2i) have been shown in preclinical and clinical studies to reduce food intake, body weight, and adiposity. Here, we investigated the effects of MetAP2i administration in a mouse model of ciliopathy produced by conditional deletion of the Thm1 gene in adulthood. Thm1 conditional knockout (cko) mice showed decreased hypothalamic proopiomelanocortin expression as well as hyperphagia, obesity, metabolic disease, and hepatic steatosis. In obese Thm1-cko mice, 2-week administration of MetAP2i reduced daily food intake and reduced body weight 17.1% from baseline (vs. 5% reduction for vehicle). This was accompanied by decreased levels of blood glucose, insulin, and leptin. Further, MetAP2i reduced gonadal adipose depots and adipocyte size and improved liver morphology. This is the first report to our knowledge of MetAP2i reducing hyperphagia and body weight and ameliorating metabolic indices in a mouse model of ciliopathy. These results support further investigation of MetAP2 inhibition as a potential therapeutic strategy for ciliary-mediated forms of obesity.

SUBMITTER: Pottorf TS 

PROVIDER: S-EPMC7098713 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

MetAP2 inhibition reduces food intake and body weight in a ciliopathy mouse model of obesity.

Pottorf Tana S TS   Fagan Micaella P MP   Burkey Bryan F BF   Cho David J DJ   Vath James E JE   Tran Pamela V PV  

JCI insight 20200130 2


The ciliopathies Bardet-Biedl syndrome and Alström syndrome are genetically inherited pleiotropic disorders with hyperphagia and obesity as primary clinical features. Methionine aminopeptidase 2 inhibitors (MetAP2i) have been shown in preclinical and clinical studies to reduce food intake, body weight, and adiposity. Here, we investigated the effects of MetAP2i administration in a mouse model of ciliopathy produced by conditional deletion of the Thm1 gene in adulthood. Thm1 conditional knockout  ...[more]

Similar Datasets

| S-EPMC2844838 | biostudies-other
2023-07-31 | GSE229799 | GEO
| S-EPMC6418345 | biostudies-literature
| S-EPMC3572566 | biostudies-literature
| S-EPMC4823743 | biostudies-literature
| S-EPMC5603516 | biostudies-literature
| S-EPMC5773056 | biostudies-literature
2010-12-30 | E-GEOD-20931 | biostudies-arrayexpress
| S-EPMC2951864 | biostudies-other
| S-EPMC1265876 | biostudies-other